Rare solid tumours as indicators of hereditary cancer syndromes

Gatta G, van der Zwan JM, Casali PG, Siesling S, Dei Tos AP, Kunkler I, et al. Rare cancers are not so rare: the rare cancer burden in Europe. Eur J Cancer. 2011;47:2493–511.

Article 
PubMed 

Google Scholar 

Richard S, Campello C, Taillandier L, Parker F, Resche F. Haemangioblastoma of the central nervous system in von Hippel-Lindau disease. Fr VHL Study Group J Intern Med. 1998;243:547–53.

CAS 

Google Scholar 

McCluggage WG, Foulkes WD. Rare and unusual tumours associated with characteristic molecular events: the importance of specialist pathology review. Histopathology. 2022;81:310–1.

Article 
PubMed 

Google Scholar 

Idos G, Valle L Lynch Syndrome. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews. 1993.

Dominguez-Valentin M, Sampson JR, Moller P, Seppala TT. Analysis in the prospective lynch syndrome database identifies sarcoma as part of the lynch syndrome tumor spectrum. Int J Cancer. 2021;148:512–3.

Article 
CAS 
PubMed 

Google Scholar 

Raymond VM, Everett JN, Furtado LV, Gustafson SL, Jungbluth CR, Gruber SB, et al. Adrenocortical carcinoma is a lynch syndrome-associated cancer. J Clin Oncol. 2013;31:3012–8.

Article 
PubMed 
PubMed Central 

Google Scholar 

Ferreira I, Wiedemeyer K, Demetter P, Adams DJ, Arends MJ, Brenn T. Update on the pathology, genetics and somatic landscape of sebaceous tumours. Histopathology. 2020;76:640–9.

Article 
PubMed 

Google Scholar 

Orta L, Klimstra DS, Qin J, Mecca P, Tang LH, Busam KJ, et al. Towards identification of hereditary DNA mismatch repair deficiency: sebaceous neoplasm warrants routine immunohistochemical screening regardless of patient’s age or other clinical characteristics. Am J Surg Pathol. 2009;33:934–44.

Article 
PubMed 

Google Scholar 

Colas C, Guerrini-Rousseau L, Suerink M, Gallon R, Kratz CP, Ayuso E, et al. ERN GENTURIS guidelines on constitutional mismatch repair deficiency diagnosis, genetic counselling, surveillance, quality of life, and clinical management. Eur J Hum Genet. 2024;32:1526–41.

Article 
PubMed 
PubMed Central 

Google Scholar 

Suwala AK, Stichel D, Schrimpf D, Kloor M, Wefers AK, Reinhardt A, et al. Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis. Acta Neuropathol. 2021;141:85–100.

Article 
CAS 
PubMed 

Google Scholar 

Campos FAB, Rouleau E, Torrezan GT, Carraro DM, Casali da Rocha JC, Mantovani HK, et al. Genetic landscape of male breast cancer. Cancers. 2021;13:3535.

Liang M, Zhang Y, Sun C, Rizeq FK, Min M, Shi T, et al. Association between CHEK2*1100delC and breast cancer: a systematic review and meta-analysis. Mol Diagn Ther. 2018;22:397–407.

Article 
CAS 
PubMed 

Google Scholar 

Schneider K, Zelley K, Nichols KE, Schwartz Levine A, Garber et al. Li-Fraumeni Syndrome. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews. 1993.

Amadou A, Achatz MIW, Hainaut P. Revisiting tumor patterns and penetrance in germline TP53 mutation carriers: temporal phases of Li-Fraumeni syndrome. Curr Opin Oncol. 2018;30:23–9.

Article 
CAS 
PubMed 

Google Scholar 

Kratz CP, Achatz MI, Brugieres L, Frebourg T, Garber JE, Greer MC, et al. Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome. Clin Cancer Res. 2017;23:e38–e45.

Article 
CAS 
PubMed 

Google Scholar 

Lalloo F, Kulkarni A, Chau C, Nielsen M, Sheaff M, Steele J, et al. Clinical practice guidelines for the diagnosis and surveillance of BAP1 tumour predisposition syndrome. Eur J Hum Genet. 2023;31:1261–9.

Article 
PubMed 
PubMed Central 

Google Scholar 

Eng C, Plitt G Multiple Endocrine Neoplasia Type 2. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews. 1993.

Wells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid. 2015;25:567–610.

Article 
PubMed 
PubMed Central 

Google Scholar 

Odintsov I, Papke DJ, George S, Padera RF, Hornick JL, Siegmund SE. Genomic profiling of cardiac angiosarcoma reveals novel targetable KDR variants, recurrent MED12 mutations, and a high burden of germline POT1 alterations. Clin Cancer Res. 2025;31:1091–102.

Article 
CAS 
PubMed 

Google Scholar 

Hirbe AC, Dehner CA, Dombi E, Eulo V, Gross AM, Sundby T, et al. Contemporary approach to neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors. Am Soc Clin Oncol Educ Book. 2024;44:e432242.

Article 
PubMed 
PubMed Central 

Google Scholar 

Carton C, Evans DG, Blanco I, Friedrich RE, Ferner RE, Farschtschi S, et al. ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1. EClinicalMedicine. 2023;56:101818.

Article 
PubMed 
PubMed Central 

Google Scholar 

Zanoletti E, Girasoli L, Borsetto D, Opocher G, Mazzoni A, Martini A. Endolymphatic sac tumour in von Hippel-Lindau disease: management strategies. Acta Otorhinolaryngol Ital. 2017;37:423–9.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Wu J, Lu J, Wu CL, Lu M. Birt-Hogg-Dube syndrome in an overall view: focus on the clinicopathological prospects in renal tumors. Semin Diagn Pathol. 2024;41:119–24.

Article 
PubMed 

Google Scholar 

Degenhardt J, Tolkach Y, Amin MB, Mosiello G, Ertoy Baydar D, Cornec-Le Gall E, et al. The impact of the new WHO classification of renal cell carcinoma on the diagnosis of hereditary leiomyomatosis and renal cell carcinoma. Nephrol Dial Transpl. 2025;40:1428–32.

Article 
CAS 

Google Scholar 

Zhang X, Zhao J, Yin X, Liang J, Wang Y, Zheng L, et al. Comprehensive molecular profiling of FH-deficient renal cell carcinoma identifies molecular subtypes and potential therapeutic targets. Nat Commun. 2025;16:4398.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Liu APY, Kelsey MM, Sabbaghian N, Park SH, Deal CL, Esbenshade AJ, et al. Clinical outcomes and complications of pituitary blastoma. J Clin Endocrinol Metab. 2021;106:351–63.

Article 
PubMed 
PubMed Central 

Google Scholar 

Brenneman M, Field A, Yang J, Williams G, Doros L, Rossi C, et al. Temporal order of RNase IIIb and loss-of-function mutations during development determines phenotype in pleuropulmonary blastoma / DICER1 syndrome: a unique variant of the two-hit tumor suppression model. F1000Res. 2015;4:214.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Witkowski L, Goudie C, Ramos P, Boshari T, Brunet JS, Karnezis AN, et al. The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic type. Gynecol Oncol. 2016;141:454–60.

Article 
PubMed 
PubMed Central 

Google Scholar 

Goudie C, Witkowski L, Vairy S, McCluggage WG, Foulkes WD. Paediatric ovarian tumours and their associated cancer susceptibility syndromes. J Med Genet. 2018;55:1–10.

Article 
PubMed 

Google Scholar 

Lohmann DR, Gerick M, Brandt B, Oelschlager U, Lorenz B, Passarge E, et al. Constitutional RB1-gene mutations in patients with isolated unilateral retinoblastoma. Am J Hum Genet. 1997;61:282–94.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Coorens THH, Treger TD, Al-Saadi R, Moore L, Tran MGB, Mitchell TJ, et al. Embryonal precursors of Wilms tumor. Science. 2019;366:1247–51.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Witkowski L, Nichols KE, Jongmans M, van Engelen N, de Krijger RR, Herrera-Mullar J, et al. Germline pathogenic SMARCA4 variants in neuroblastoma. J Med Genet. 2023;60:987–92.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Zavoshi S, Lu E, Boutros PC, Zhang L, Harari A, Hatchell KE, et al. Fumarate hydratase variants and their association with paraganglioma/pheochromocytoma. Urology. 2023;176:106–14.

Article 
PubMed 

Google Scholar 

Pinto EM, Rodriguez-Galindo C, Lam CG, Ruiz RE, Zambetti GP, Ribeiro RC. Adrenocortical tumors in children with constitutive chromosome 11p15 paternal uniparental disomy: implications for diagnosis and treatment. Front Endocrinol. 2021;12:756523.

Article 

Google Scholar 

Sargen MR, Merrill SL, Chu EY, Nathanson KL. CDKN2A mutations with p14 loss predisposing to multiple nerve sheath tumours, melanoma, dysplastic naevi and internal malignancies: a case series and review of the literature. Br J Dermatol. 2016;175:785–9.

Article 
CAS 
PubMed 

Google Scholar 

Stratakis CA Carney Complex. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews. 1993.

Golden T, Siordia JA. Osteochondromyxoma: Review of a rare Carney complex criterion. J Bone Oncol. 2016;5:194–7.

Article 
PubMed 
PubMed Central 

Google Scholar 

Apellaniz-Ruiz M, Segni M, Kettwig M, Gluer S, Pelletier D, Nguyen VH, et al. Mesenchymal hamartoma of the liver and DICER1 syndrome. N Engl J Med. 2019;380:1834–42.

Article 
CAS 
PubMed 

Google Scholar 

Mitchell SG, Schultz KAP, Rytting H, Kostelecky N, Hill DA, Dehner LP. DICER1-associated hepatic cystic neoplasm with pleuropulmonary blastoma-like features: a novel clinicopathologic diagnosis. Mod Pathol. 2022;35:676–9.

Article 
CAS 
PubMed 

Google Scholar 

Pilarski R, Byrne L, Carlo MI, Hanson H, Cebulla C, Abdel-Rahman M BAP1 Tumor Predisposition Syndrome. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews. 1993.

Bruinsma FJ, Dowty JG, Win AK, Goddard LC, Agrawal P, Attina D, et al. Update of penetrance estimates in Birt-Hogg-Dube syndrome. J Med Genet. 2023;60:317–26.

Article 
CAS 
PubMed 

Google Scholar 

Ouchene L, Udupa M, Mija LA, Moussa S, Chergui M, Watters KA, et al. Assessing the diagnostic metrics of cutaneous leiomyomas in hereditary leiomyomatosis and renal cell cancer syndrome: an observational study. J Am Acad Dermatol. 2025;93:226–8.

Article 
CAS 
PubMed 

Google Scholar 

Carney JA, Stratakis CA. Epithelioid blue nevus and psammomatous melanotic schwannoma: the unusual pigmented skin tumors of the Carney complex. Semin Diagn Pathol. 1998;15:216–24.

CAS 
PubMed 

Google Scholar 

Gurbuz AK, Giardiello FM, Petersen GM, Krush AJ, Offerhaus GJ, Booker SV, et al. Desmoid tumours in familial adenomatous polyposis. Gut. 1994;35:377–81.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Nusse R, Clevers H. Wnt/beta-catenin signaling, disease, and emerging therapeutic modalities. Cell. 2017;169:985–99.

Article 
CAS 
PubMed 

Google Scholar 

Kasper B, Baldini EH, Bonvalot S, Callegaro D, Cardona K, Colombo C, et al. Current management of desmoid tumors: a review. JAMA Oncol. 2024;10:1121–8.

Article 
PubMed 

Google Scholar 

Evans DG, Ladusans EJ, Rimmer S, Burnell LD, Thakker N, Farndon PA. Complications of the naevoid basal cell carcinoma syndrome: results of a population based study. J Med Genet. 1993;30:460–4.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

MacDonald-Jankowski DS. Keratocystic odontogenic tumour: systematic review. Dentomaxillofac Radio. 2011;40:1–23.

Article 
CAS 

Google Scholar 

Else T, Rodriguez-Galindo C. 5th International ACC Symposium: hereditary predisposition to childhood ACC and the associated molecular phenotype: 5th international ACC symposium session: not just for kids! Horm Cancer. 2016;7:36–9.

Article 
CAS 
PubMed 

Google Scholar 

Clay MR, Pinto EM, Fishbein L, Else T, Kiseljak-Vassiliades K. Pathological and genetic stratification for management of adrenocortical carcinoma. J Clin Endocrinol Metab. 2022;107:1159–69.

Article 
PubMed 
PubMed Central 

Google Scholar 

Weber ML, Schneider DT, Offenmuller S, Kaatsch P, Einsiedel HG, Benesch M, et al. Pediatric colorectal carcinoma is associated with excellent outcome in the context of cancer predisposition syndromes. Pediatr Blood Cancer. 2016;63:611–7.

Article 
PubMed 

Google Scholar 

Rebuzzi F, Ulivi P, Tedaldi G Genetic predisposition to colorectal cancer: how many and which genes to test? Int J Mol Sci. 2023;24:2137.

Goudie C, Witkowski L, Cullinan N, Reichman L, Schiller I, Tachdjian M, et al. Performance of the McGill interactive pediatric oncogenetic guidelines for identifying cancer predisposition syndromes. JAMA Oncol. 2021;7:1806–14.

Article 
PubMed 
PubMed Central 

Google Scholar 

McConechy MK, Farkkila A, Horlings HM, Talhouk A, Unkila-Kallio L, van Meurs HS, et al. Molecularly defined adult granulosa cell tumor of the ovary: the clinical phenotype. J Natl Cancer Inst. 2016;108:djw134.

Quirk JT, Natarajan N. Ovarian cancer incidence in the United States, 1992-1999. Gynecol Oncol. 2005;97:519–23.

Article 
PubMed 

Google Scholar 

Rabban JT, Karnezis AN, Devine WP. Practical roles for molecular diagnostic testing in ovarian adult granulosa cell tumour, Sertoli-Leydig cell tumour, microcystic stromal tumour and their mimics. Histopathology. 2020;76:11–24.

Article 
PubMed 

Google Scholar 

Plevova P, Gerzova H. Genetic causes of rare pediatric ovarian tumors. Klin Onkol. 2019;32:79–91.

Article 
PubMed 

Google Scholar 

Stratakis CA, Carney JA. The triad of paragangliomas, gastric stromal tumours and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney-Stratakis syndrome): molecular genetics and clinical implications. J Intern Med. 2009;266:43–52.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Dasari A, Wallace K, Halperin DM, Maxwell J, Kunz P, Singh S, et al. Epidemiology of neuroendocrine neoplasms in the US. JAMA Netw Open. 2025;8:e2515798.

Article 
PubMed 
PubMed Central 

Google Scholar 

Rindi G, Wiedenmann B. Neuroendocrine neoplasia of the gastrointestinal tract revisited: towards precision medicine. Nat Rev Endocrinol. 2020;16:590–607.

Article 
PubMed 

Google Scholar 

Metz DC, Cadiot G, Poitras P, Ito T, Jensen RT. Diagnosis of Zollinger-Ellison syndrome in the era of PPIs, faulty gastrin assays, sensitive imaging and limited access to acid secretory testing. Int J Endocr Oncol. 2017;4:167–85.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Scarpa A, Chang DK, Nones K, Corbo V, Patch AM, Bailey P, et al. Whole-genome landscape of pancreatic neuroendocrine tumours. Nature. 2017;543:65–71.

Article 
CAS 
PubMed 

Google Scholar 

Smith NJ, Mukherjee D, Wang Y, Brazauskas R, Nelson AA, Cortina CS. Epidemiology and outcomes of primary pediatric lung malignancies: Updates from the SEER database. Am J Surg. 2021;222:861–6.

Article 
PubMed 
PubMed Central 

Google Scholar 

Thibodeau ML, O’Neill K, Dixon K, Reisle C, Mungall KL, Krzywinski M, et al. Improved structural variant interpretation for hereditary cancer susceptibility using long-read sequencing. Genet Med. 2020;22:1892–7.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Horton C, Hoang L, Zimmermann H, Young C, Grzybowski J, Durda K, et al. Diagnostic outcomes of concurrent DNA and RNA sequencing in individuals undergoing hereditary cancer testing. JAMA Oncol. 2024;10:212–9.

Article 
PubMed 
PubMed Central 

Google Scholar 

Jonasch E, Donskov F, Iliopoulos O, Rathmell WK, Narayan VK, Maughan BL, et al. Belzutifan for renal cell carcinoma in von Hippel-Lindau disease. N Engl J Med. 2021;385:2036–46.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Gross AM, Wolters PL, Dombi E, Baldwin A, Whitcomb P, Fisher MJ, et al. Selumetinib in children with inoperable plexiform neurofibromas. N Engl J Med. 2020;382:1430–42.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Guerrini-Rousseau L, Varlet P, Colas C, Andreiuolo F, Bourdeaut F, Dahan K, et al. Constitutional mismatch repair deficiency-associated brain tumors: report from the European C4CMMRD consortium. Neurooncol Adv. 2019;1:vdz033.

PubMed 
PubMed Central 

Google Scholar 

Gounder M, Schoffski P, Jones RL, Agulnik M, Cote GM, Villalobos VM, et al. Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study. Lancet Oncol. 2020;21:1423–32.

Article 
CAS 
PubMed 

Google Scholar 

Boyd N, Dancey JE, Gilks CB, Huntsman DG. Rare cancers: a sea of opportunity. Lancet Oncol. 2016;17:e52–e61.

Article 
PubMed 

Google Scholar 

Pappo AS, Furman WL, Schultz KA, Ferrari A, Helman L, Krailo MD. Rare tumors in children: progress through collaboration. J Clin Oncol. 2015;33:3047–54.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar